FDA gets biomarker database license from GVK Bio

Singapore: GVK Biosciences is extending its Clinical Biomarker Database (Gobiom) license to the Biomarker Qualification ...

February 5, 2013 | Tuesday | Regulatory
Otsuka, Lundbeck files NDA for schizophrenia drug

Singapore: Japanese firm Otsuka Pharmaceutical and global firm H Lundbeck have submitted a New Drug Application (NDA) to...

July 15, 2014 | Tuesday | News
NIH study: Diabetes drug Metformin extends life

Singapore: Long-term treatment with the type 2 diabetes drug metformin improves health and longevity of male mice when s...

July 31, 2013 | Wednesday | News
Accelerating drug discovery process

In the last few years, biotech companies in Korea have targeted innovation in drug development and are building platform...

March 26, 2012 | Monday | News
Boehringer to open $46 mn biologics plant in Shanghai

Singapore: German drug major Boehringer Ingelheim has planned to build a biologics plant in Shanghai, China, to offer co...

June 10, 2013 | Monday | News
Recycled plastic can kill drug-resistant fungi

Singapore: Researchers at Singapore's Institute of Bioengineering and Nanotechnology (IBN) and California's IBM Research...

December 10, 2013 | Tuesday | News
Novartis liver cancer trial with Afinitor flops

Singapore: Novartis highlighted that the results of a global phase III study showed that Afinitor (everolimus) did not e...

August 9, 2013 | Friday | News
Oramed submits pre-IND for exenatide to FDA

Singapore: Oramed Pharmaceuticals, a developer of oral drug delivery systems, submitted a pre-Investigational New Drug (...

August 2, 2013 | Friday | Regulatory
Aussie drug delivery firm raises $19.3 mn

Singapore: Australian drug delivery company, Phosphagenics, has raised $19.3 million via a placement of $16.3 million to...

July 15, 2014 | Tuesday | News
Bayer initiates Phase II/III trial of a new compound for Hemophilia A

Singapore, July 09, 2012: Bayer HealthCare has started to enroll patients in an international Phase II/III trial to eval...

April 24, 2012 | Tuesday | News
APAC ovarian cancer drug market to grow modestly'

Singapore: Asia Pacific (APAC) therapeutics market for ovarian cancer will undergo a modest rise in value, from $294.3 m...

January 30, 2015 | Friday | Analysis
Deal with Janssen gets Astellas $65 million up-front

Singapore: Astellas Pharma signed a license agreement with Janssen Biotech under which Janssen has an exclusive right to...

October 2, 2012 | Tuesday | News
Lorcaserin receives positive vote from FDA advisory committee

Singapore: Eisai announced that the US Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory C...

April 24, 2012 | Tuesday | News
Biodiem gets US patent allowance for antifungal therapy

Singapore: Australian infectious disease therapy and vaccine development company BioDiem has received notice of Allowanc...

April 24, 2012 | Tuesday | News
Minoryx Therapeutics receives Orphan Drug Designation for its lead candidate MIN-102

Minoryx Therapeutics, a drug development company specialized in the discovery and development of new drugs for orphan di...

February 22, 2017 | Wednesday | News
Apollo Therapeutics launched the first drug discovery programme

Apollo Therapeutics, the collaborative venture between three world-leading UK universities and three global pharmaceutic...

February 22, 2017 | Wednesday | News
New CoolPal Vertos Advance launched by Pelican BioThermal

US based Pelical BioThermal which is a global leader providing the broadcast and most innovative range of temperature-co...

January 19, 2017 | Thursday | News
According to GBI Research, the growth will primarily be driven by the emergence of novel therapeutics

Singapore: The treatment market for multiple myeloma across the Asia-Pacific (APAC) countries of China, India, Japan, an...

January 19, 2017 | Thursday | News